Centene (CNC) Competitors $33.06 -0.25 (-0.75%) Closing price 03:59 PM EasternExtended Trading$33.04 -0.02 (-0.05%) As of 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNC vs. ELV, MOH, SEM, CI, HUM, UNH, JYNT, AEMD, BMY, and HCAShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Cigna Group (CI), Humana (HUM), UnitedHealth Group (UNH), Joint (JYNT), Aethlon Medical (AEMD), Bristol Myers Squibb (BMY), and HCA Healthcare (HCA). These companies are all part of the "medical" sector. Centene vs. Its Competitors Elevance Health Molina Healthcare Select Medical Cigna Group Humana UnitedHealth Group Joint Aethlon Medical Bristol Myers Squibb HCA Healthcare Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations. Is ELV or CNC more profitable? Elevance Health has a net margin of 3.23% compared to Centene's net margin of 2.04%. Elevance Health's return on equity of 18.61% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Elevance Health3.23% 18.61% 6.80% Centene 2.04%14.56%4.75% Does the media prefer ELV or CNC? In the previous week, Centene had 39 more articles in the media than Elevance Health. MarketBeat recorded 98 mentions for Centene and 59 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.75 beat Centene's score of -0.06 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 23 Very Positive mention(s) 4 Positive mention(s) 28 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Positive Centene 16 Very Positive mention(s) 12 Positive mention(s) 30 Neutral mention(s) 22 Negative mention(s) 9 Very Negative mention(s) Neutral Do analysts rate ELV or CNC? Elevance Health currently has a consensus price target of $498.87, indicating a potential upside of 43.87%. Centene has a consensus price target of $68.87, indicating a potential upside of 108.31%. Given Centene's higher probable upside, analysts plainly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elevance Health 0 Sell rating(s) 4 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.75Centene 0 Sell rating(s) 10 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.41 Which has stronger valuation and earnings, ELV or CNC? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevance Health$177.01B0.44$5.98B$25.6313.53Centene$163.07B0.10$3.31B$6.714.93 Do insiders & institutionals hold more shares of ELV or CNC? 89.2% of Elevance Health shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 0.4% of Centene shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, ELV or CNC? Elevance Health has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. SummaryElevance Health beats Centene on 12 of the 16 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneMED IndustryMedical SectorNYSE ExchangeMarket Cap$16.45B$41.90B$5.45B$20.45BDividend YieldN/A111.92%5.22%3.72%P/E Ratio4.939.2627.2427.83Price / Sales0.101.35426.3746.02Price / Cash3.379.2226.2118.22Price / Book0.632.697.924.59Net Income$3.31B$2.64B$3.17B$982.91M7 Day Performance-39.03%-8.25%4.40%1.73%1 Month Performance-40.07%-13.28%2.64%4.26%1 Year Performance-50.19%-31.50%35.04%14.35% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9699 of 5 stars$33.06-0.8%$68.87+108.3%-49.9%$16.45B$163.07B4.9360,500Trending NewsAnalyst RevisionHigh Trading VolumeELVElevance Health4.966 of 5 stars$389.42+2.1%$498.87+28.1%-34.2%$87.98B$183.12B15.19102,300MOHMolina Healthcare4.9822 of 5 stars$297.09+0.0%$364.21+22.6%-18.3%$16.10B$40.65B14.3518,000Trending NewsSEMSelect Medical5 of 5 stars$15.19-0.5%$26.00+71.2%-57.7%$1.95B$5.19B11.3444,100Positive NewsCICigna Group4.9529 of 5 stars$330.12+1.2%$380.39+15.2%+0.1%$88.19B$254.47B18.2871,300High Trading VolumeHUMHumana4.6257 of 5 stars$244.30+1.0%$280.76+14.9%-35.3%$29.49B$120.26B17.2867,100Positive NewsAnalyst RevisionUNHUnitedHealth Group4.9977 of 5 stars$311.89+0.9%$415.57+33.2%-36.7%$282.93B$400.28B13.06400,000Positive NewsJYNTJoint3.006 of 5 stars$11.54+1.1%$15.50+34.3%-11.5%$176.60M$52.79M-19.90320News CoverageAEMDAethlon Medical2.2815 of 5 stars$1.20-4.0%$56.00+4,566.7%-64.8%$3.11M$570K-0.0910Analyst ForecastHigh Trading VolumeBMYBristol Myers Squibb4.9375 of 5 stars$46.35flat$58.00+25.1%+18.5%$94.33B$48.30B17.3634,300Positive NewsHCAHCA Healthcare4.8162 of 5 stars$383.21+1.0%$395.71+3.3%+16.4%$92.19B$70.60B17.04294,000Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies ELV Alternatives MOH Alternatives SEM Alternatives CI Alternatives HUM Alternatives UNH Alternatives JYNT Alternatives AEMD Alternatives BMY Alternatives HCA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNC) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
